Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3PZV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,695
Award facts
- Contract value 100% obligated
- $5,695.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Rexulti 1 mg tablets in a quantity of 30 tablets, with a contract ceiling value of $5,695.32. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 28, 2025.
This delivery order represents a continuation of AmerisourceBergen Drug Corp's ongoing pharmaceutical supply relationship with the Defense Logistics Agency. The company holds a $999,999,999.00 prime indefinite delivery vehicle designated SPE2DX with DLA Troop Support Medical that extends through December 2026, serving as the comprehensive global pharmaceutical support contract enabling deliveries of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs. Rexulti, an atypical antipsychotic medication, falls within the neurological and psychiatric therapeutics domain that AmerisourceBergen supplies through its federal contract portfolio. The firm fixed price structure and rapid completion timeline reflect the operational efficiency typical of delivery orders placed against established pharmaceutical prime vendor contracts supporting Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3PZV?
SPE2DR26F3PZV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F3PZV worth?
The government has obligated $5,695 on SPE2DR26F3PZV.
Is contract SPE2DR26F3PZV an order under another contract?
Yes. SPE2DR26F3PZV is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3PZV competed?
The extent of competition for SPE2DR26F3PZV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award